How Big Will the SpaceX IPO Be?
Operated up to now as a private business, SpaceX will…
Sell
14
XXII Quote, Financials, Valuation and Earnings
Last price:
$5.87
Seasonality move
:
44.66%
Day range:
$5.30 - $5.97
52-week range:
$5.30 - $1,207.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.20x
P/B ratio:
0.16x
Volume:
71.6K
Avg. volume:
23.1K
1-year change:
-99.5%
Market cap:
$3M
Revenue:
$24.4M
EPS (TTM):
-$425.78
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, 22nd Century Group, Inc. has 2223.58% upside to fair value with a price target of $9.00 per share.
XXII vs. S&P 500
-
Over the past 5 trading days, 22nd Century Group, Inc. has underperformed the S&P 500 by -24.33% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
22nd Century Group, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
22nd Century Group, Inc. revenues have been falling on a year-over-year basis for 11 quarters in a row. In the most recent quarter 22nd Century Group, Inc. reported revenues of $4M.
Earnings Growth
-
22nd Century Group, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter 22nd Century Group, Inc. reported earnings per share of $0.46.
Enterprise value:
2M
EV / Invested capital:
--
Price / LTM sales:
0.20x
EV / EBIT:
--
EV / Revenue:
0.11x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-0.14x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$4M
Return On Assets:
-58.76%
Net Income Margin (TTM):
-80.68%
Return On Equity:
-207.64%
Return On Invested Capital:
-107.23%
Operating Margin:
-77.31%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $34.8M | $27.7M | $18.1M | $5.9M | $4M | |
| Gross Profit | -$2.4M | -$9.4M | -$4M | -$691K | -$1.2M | |
| Operating Income | -$42.1M | -$42M | -$12.6M | -$3.4M | -$3.1M | |
| EBITDA | -$37.5M | -$40.6M | -$11.4M | -$3M | -$2.8M | |
| Diluted EPS | -$25,407,318.28 | -$2,978.08 | -$6,351.65 | -$74.30 | $6.93 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $62.2M | $64.4M | $40.6M | $15.8M | $22.9M | |
| Total Assets | $86.5M | $142.2M | $64.2M | $26.2M | $32.4M | |
| Current Liabilities | $7M | $18.7M | $39.8M | $14.4M | $10.5M | |
| Total Liabilities | $7.4M | $21.1M | $50.4M | $22.7M | $14M | |
| Total Equity | $79M | $121.1M | $13.8M | $3.5M | $18.4M | |
| Total Debt | $2.2M | $7.6M | $26M | $9.1M | $3.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$69.3M | -$14.8M | -$14.9M | -$3M | -$4M | |
| Cash From Investing | $39.6M | -$655K | $130K | -$70K | -$522K | |
| Cash From Financing | $37.7M | $10.4M | $14.2M | $7.1M | $6.3M | |
| Free Cash Flow | -$75.2M | -$16.1M | -$15M | -$3M | -$4M | |
XXII
Sector
Market Cap
$3M
$110.1M
Price % of 52-Week High
0.48%
75.48%
Dividend Yield
0%
0%
Shareholder Yield
-3123.46%
2.42%
1-Year Price Total Return
-99.5%
-2.54%
Beta (5-Year)
1.067
0.246
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$6.93
200-day SMA
Sell
Level
$86.18
Bollinger Bands (100)
Sell
Level
11.35 - 22.97
Chaikin Money Flow
Sell
Level
-45.1K
20-day SMA
Sell
Level
$10.03
Relative Strength Index (RSI14)
Sell
Level
23.59
ADX Line
Sell
Level
26.1
Williams %R
Buy
Level
-93.5442
50-day SMA
Sell
Level
$12.73
MACD (12, 26)
Buy
Level
1.63
25-day Aroon Oscillator
Sell
Level
-88
On Balance Volume
Sell
Level
-118K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-26.2001)
Sell
CA Score
(Annual)
Level (-5.3109)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (8.3668)
Buy
Piotroski F Score
(Annual)
Level (7)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
22nd Century Group, Inc. is a biotechnology company, which engages in the business of tobacco harm reduction, reduced nicotine tobacco, and improvement of health and wellness through plant science. It operates through the Tobacco and Hemp/Cannabis segments. The Tobacco segment manufactures branded filtered cigars and cigarettes. The Hemp/Cannabis segment focuses on the bulk ingredient distillate or isolate. The company was founded on September 12, 2005 and is headquartered in Mocksville, NC.
Stock Forecast FAQ
In the current month, XXII has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The XXII average analyst price target in the past 3 months is $9.00.
-
Where Will 22nd Century Group, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that 22nd Century Group, Inc. share price will rise to $9.00 per share over the next 12 months.
-
What Do Analysts Say About 22nd Century Group, Inc.?
Analysts are divided on their view about 22nd Century Group, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that 22nd Century Group, Inc. is a Sell and believe this share price will drop from its current level to $9.00.
-
What Is 22nd Century Group, Inc.'s Price Target?
The price target for 22nd Century Group, Inc. over the next 1-year time period is forecast to be $9.00 according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is XXII A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for 22nd Century Group, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of XXII?
You can purchase shares of 22nd Century Group, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase 22nd Century Group, Inc. shares.
-
What Is The 22nd Century Group, Inc. Share Price Today?
22nd Century Group, Inc. was last trading at $5.87 per share. This represents the most recent stock quote for 22nd Century Group, Inc.. Yesterday, 22nd Century Group, Inc. closed at $5.81 per share.
-
How To Buy 22nd Century Group, Inc. Stock Online?
In order to purchase 22nd Century Group, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get XXII Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
XXII
Sector
P/E ratio
--
17.65x
PEG ratio
0.00x
0.12x
P/B ratio
0.16x
1.51x
Price / LTM sales
0.20x
0.52x
Growth Metrics
XXII
Sector
Revenue growth
-32.54%
2.79%
Earnings growth
100.62%
2.3%
Revenue (5-year growth)
-1.15%
3.36%
Earnings forecast
--
$0.26
Profitability
XXII
Sector
Profitability FY 2024
-$2.8M
$254.9M
Return on invested capital
-107.23%
4.33%
Return on assets
-58.76%
3.03%
Return on equity
-207.64%
7.7%
Earnings Date
Last Earnings Date
Nov
4
Next Earnings Date
Mar
19
Estimated Next Earnings Date
Feb
3
Balance Sheet
XXII
Sector
Total cash
$4.8M
$85.8M
Short term investments
--
$31.1M
Total assets
$21.7M
$1.1B
Long term debt
$3.7M
$5.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
53
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Sell
40
BILL alert for Feb 7
Bill Holdings, Inc. [BILL] is up 37.11% over the past day.
Buy
75
PRLB alert for Feb 7
Proto Labs, Inc. [PRLB] is up 28.33% over the past day.
Sell
30
MSTR alert for Feb 7
Strategy, Inc. [MSTR] is up 26.08% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
